MENU
BRNS
AS OF
Dec 12 closing price
Price
$0.68
Change
-$0.04 (-5.56%)
Capitalization
27.74M
96 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
BRNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Barinthus Biotherapeutics (BRNS) Ownership - Who owns Barinthus Biotherapeutics?

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.74M
P/E Ratio
N/A
Total Cash
74.27M
Projected Growth
N/A
Total Debt
11.57M
Revenue
N/A
Risk (Beta)
-1.98
Dividend Yield
N/A
Total Cash/Share
1.82
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

BRNS
Capitalization
27.7M
P/E Ratio
N/A
Risk (Beta)
-1.98
Dividend Yield
N/A
Total Cash
74.3M
Total Cash/Share
1.82
Total Debt
11.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
84.5M
P/B Ratio
0.33
Cash Flow
N/A
Earnings
-1.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
8.04
Current Revenue Per Employee
115146.16
Dividends Per Share - Security
N/A
EBITDA
-69.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-50.94
Shares Held By Institutions
10.4M
Shares Outstanding - Current
40.8M
Total Liabilities
24.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-40.364
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BRNS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BRNS showed earnings on November 07, 2025. You can read more about the earnings report here.
View AI-Driven Trading for BRNS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com